Christopher W. Fulton

Array ( [id] => 5875194 [patent_doc_number] => 20060166892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Treatment of cell proliferative disorders with chlorotoxin' [patent_app_type] => utility [patent_app_number] => 10/522810 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14262 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166892.pdf [firstpage_image] =>[orig_patent_app_number] => 10522810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725726 [patent_doc_number] => 20030208038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds' [patent_app_type] => new [patent_app_number] => 10/449299 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 36500 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20030208038.pdf [firstpage_image] =>[orig_patent_app_number] => 10449299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770634 [patent_doc_number] => 20030216574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Pyrazine based inhibitors of glycogen synthase kinase 3' [patent_app_type] => new [patent_app_number] => 10/447031 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14966 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216574.pdf [firstpage_image] =>[orig_patent_app_number] => 10447031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928557 [patent_doc_number] => 07314867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Pharmaceutical composition comprising a retro-iverso isomer peptide' [patent_app_type] => utility [patent_app_number] => 10/517355 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2261 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314867.pdf [firstpage_image] =>[orig_patent_app_number] => 10517355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912862 [patent_doc_number] => 20050176620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Crosslinked compounds and methods of making and using thereof' [patent_app_type] => utility [patent_app_number] => 10/519173 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21639 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176620.pdf [firstpage_image] =>[orig_patent_app_number] => 10519173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679059 [patent_doc_number] => 20030229200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activity' [patent_app_type] => new [patent_app_number] => 10/435466 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65036 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229200.pdf [firstpage_image] =>[orig_patent_app_number] => 10435466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168769 [patent_doc_number] => 07666981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-02-23 [patent_title] => 'Inhibitors of prostasin' [patent_app_type] => utility [patent_app_number] => 10/434349 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 4945 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666981.pdf [firstpage_image] =>[orig_patent_app_number] => 10434349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363382 [patent_doc_number] => 20040014946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Protein interaction method and composition' [patent_app_type] => new [patent_app_number] => 10/422561 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12882 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014946.pdf [firstpage_image] =>[orig_patent_app_number] => 10422561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297976 [patent_doc_number] => 20040214998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Purified Cys Moiety for Iron Reductase, and Method for Obtaining and Using Same' [patent_app_type] => new [patent_app_number] => 10/249607 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3718 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214998.pdf [firstpage_image] =>[orig_patent_app_number] => 10249607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875173 [patent_doc_number] => 20060166872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia' [patent_app_type] => utility [patent_app_number] => 10/511484 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12129 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166872.pdf [firstpage_image] =>[orig_patent_app_number] => 10511484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367227 [patent_doc_number] => 20040092443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Long-acting exendins and exendin agonists' [patent_app_type] => new [patent_app_number] => 10/408262 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5601 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092443.pdf [firstpage_image] =>[orig_patent_app_number] => 10408262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702091 [patent_doc_number] => 20030224971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Manufacture of polyglutamate-therapeutic agent conjugates' [patent_app_type] => new [patent_app_number] => 10/404152 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9068 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224971.pdf [firstpage_image] =>[orig_patent_app_number] => 10404152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341836 [patent_doc_number] => 20040191330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Daily skin care regimen' [patent_app_type] => new [patent_app_number] => 10/404174 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10408 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191330.pdf [firstpage_image] =>[orig_patent_app_number] => 10404174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405284 [patent_doc_number] => 20040024062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Hydroxy acid integrin antagonists' [patent_app_type] => new [patent_app_number] => 10/381825 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13243 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024062.pdf [firstpage_image] =>[orig_patent_app_number] => 10381825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632264 [patent_doc_number] => 20060148734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Diaminoacid-aminoacid-polyamine based gemini surfactant compounds' [patent_app_type] => utility [patent_app_number] => 10/508887 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14358 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148734.pdf [firstpage_image] =>[orig_patent_app_number] => 10508887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733450 [patent_doc_number] => 20060258567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Xcrf polynucleotides and polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/510002 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78609 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258567.pdf [firstpage_image] =>[orig_patent_app_number] => 10510002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314172 [patent_doc_number] => 20040033938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis' [patent_app_type] => new [patent_app_number] => 10/393098 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8016 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033938.pdf [firstpage_image] =>[orig_patent_app_number] => 10393098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281265 [patent_doc_number] => 20040063642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Novel benzimidazolone peptidomimetics as thrombin receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/390098 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10682 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063642.pdf [firstpage_image] =>[orig_patent_app_number] => 10390098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822092 [patent_doc_number] => 20030220253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Inhibitors for use in hemostasis' [patent_app_type] => new [patent_app_number] => 10/385015 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22635 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220253.pdf [firstpage_image] =>[orig_patent_app_number] => 10385015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7139031 [patent_doc_number] => 20050182246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Atomic structure of the hemalbumin complex and its use in designing therapeutic' [patent_app_type] => utility [patent_app_number] => 10/506043 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21572 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182246.pdf [firstpage_image] =>[orig_patent_app_number] => 10506043 [rel_patent_id] =>[rel_patent_doc_number] =>)